Rahman Farhan N, Nawar Afra, Nye Jonathon A, Choi Jaiyoun, Lambert Tamara P, Robinson Madeline, Gazi Asim H, Abbaraju Vikram, Tomic Nikolina, Harrison Anna B, Jaquemet Nora, Mermin-Bunnell Kellen, Mesfin Hewitt, Gray Trinity A, Welsh Justine W, Dunn Kelly E, Bikson Marom, Vaccarino Viola, Shah Amit J, Inan Omer T, Bremner James Douglas
School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
School of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, GA, USA.
Neuromodulation. 2025 Jun 23. doi: 10.1016/j.neurom.2025.04.012.
Opioid use disorder (OUD) is associated with considerable morbidity and mortality with limited treatment approaches. Understanding brain mechanisms in response to treatment could be useful in guiding future developments in treatment approaches.
The purpose of this study was to assess the effects of transcutaneous cervical vagus nerve stimulation (tcVNS) on brain response to opioid use cues in patients with OUD in opioid withdrawal.
Patients with OUD who were in the early stage of recovery and/or on medication underwent brain imaging with positron emission tomography and radiolabeled water in conjunction with stimulation with active tcVNS or sham devices and exposure to opioid-use-related cues.
tcVNS caused a relative increase in function in the anterior cingulate, dorsal anterior cingulate, and left inferior frontal gyrus during exposure to opioid cues. There also was a pattern of increased activation in the ventral striatum and orbitofrontal cortex.
tcVNS modulates brain areas implicated in opioid addiction, suggesting a useful role as an adjunctive therapy for OUD.
The Clinicaltrials.gov registration number for the study is NCT04556552.
阿片类物质使用障碍(OUD)与相当高的发病率和死亡率相关,且治疗方法有限。了解治疗过程中的脑机制可能有助于指导未来治疗方法的发展。
本研究的目的是评估经皮颈迷走神经刺激(tcVNS)对处于阿片类物质戒断期的OUD患者大脑对阿片类物质使用线索反应的影响。
处于康复早期和/或正在接受药物治疗的OUD患者接受正电子发射断层扫描和放射性标记水的脑成像,同时使用有源tcVNS或假装置进行刺激,并暴露于与阿片类物质使用相关的线索中。
在暴露于阿片类线索期间,tcVNS导致前扣带回、背侧前扣带回和左侧额下回的功能相对增加。腹侧纹状体和眶额皮质也存在激活增加的模式。
tcVNS调节与阿片类成瘾相关的脑区,表明其作为OUD辅助治疗具有一定作用。
该研究在Clinicaltrials.gov上的注册号为NCT04556552。